Alert

Recommended Alerts

Sign Up For Alerts

SEC Charges Life Sciences Company with Regulation FD Violations

On August 20, 2019, the SEC settled charges against TherapeuticsMD, a Florida-based life sciences company, for violating Regulation FD by selectively communicating to sell-side analysts information about meetings with FDA.

Read More

Draft Guidance Clarifies How FDA Plans To Regulate Certain Software "Apps"

Practices: Life Sciences, FDA Regulatory, Advertising & Promotion, Congressional Investigations & Public Policy, Due Diligence Reviews & Transactional Support, FDA Enforcement Actions & Litigation, Post-Approval Compliance, Regulatory Strategy, Product Development & Product Approvals

Printer-Friendly Version

Cookie Settings